Imlygic 10e8 plaque forming units (PFU) / mL solution for injection
- Licence status
- Active substances
- Talimogene laherparepvec
- Dosage Form
- Solution for injection
- Licence number
- EU/1/15/1064/002
- Licence holder
- Amgen Europe B.V.
Product documents
Licence information
- ATC code
- L01XC Monoclonal antibodies, L01XC19 ZZZ Blinatumomab
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued